Literature DB >> 2026806

CT-pathologic correlation of axillary lymph nodes in breast carcinoma.

D E March1, R J Wechsler, A B Kurtz, A L Rosenberg, L Needleman.   

Abstract

A prospective study was performed to determine whether thoracic CT yielded useful information regarding the status of axillary lymph nodes (LNs) in patients with breast cancer. Thirty-five consecutive patients with clinically suspected stage II or III breast carcinomas were scanned preoperatively from the supraclavicular regions to the lung bases. Axillary LNs measuring greater than or equal to 1 cm were considered abnormal. The lymph nodes were classified according to their relationship to the pectoralis muscle. Extracapsular lymph node extension was diagnosed when there was irregularity and spiculation of the lymph node margin with surrounding fatty infiltration. Correlation with axillary dissection was obtained in 20 patients, giving a positive predictive value for axillary metastases of 89% with 50% sensitivity, 75% specificity, and 20% negative predictive value. CT was also able to detect the level of axillary involvement accurately when the lymph nodes were enlarged and to evaluate extracapsular LN extension. Although superior to physical examination, CT was not an accurate predictor of axillary LN involvement, primarily because of its low negative predictive value.

Entities:  

Mesh:

Year:  1991        PMID: 2026806     DOI: 10.1097/00004728-199105000-00017

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  19 in total

Review 1.  Axillary staging of breast cancer and the sentinel node.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

2.  MR imaging-guided axillary node biopsy for breast cancer: initial findings.

Authors:  Takuji Yamagami; Sachiko Yuen; Kiyoshi Sawai; Tsunehiko Nishimura
Journal:  Eur Radiol       Date:  2003-06-14       Impact factor: 5.315

3.  [Non-invasive imaging modalities for preoperative axillary lymph node staging in patients with breast cancer].

Authors:  K Wasser; A Schnitzer; J Brade; S O Schoenberg
Journal:  Radiologe       Date:  2010-11       Impact factor: 0.635

Review 4.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

5.  Utility of Ultrasound and Mammography in Detection of Negative Axillary Nodal Metastasis in Breast Cancer.

Authors:  Anam Khan; Imrana Masroor; Kumail Khandwala; Summar-Un-Nisa Abbasi; Muhammad Usman Tariq
Journal:  Cureus       Date:  2020-01-17

Review 6.  Diagnosis of axillary lymph node metastases in patients with breast cancer.

Authors:  M Noguchi; N Katev; I Miyazaki
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Authors:  I C Smith; K N Ogston; P Whitford; F W Smith; P Sharp; M Norton; I D Miller; A K Ah-See; S D Heys; J A Jibril; O Eremin
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

8.  A comparison between ultrasonography and mammography, computed tomography and digital subtraction angiography for the detection of breast cancers.

Authors:  N Tohnosu; K Okuyama; Y Koide; T Kikuchi; T Awano; H Matsubara; T Sano; H Nakaichi; Y Funami; K Matsushita
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

9.  Incidental breast lesions detected on CT: what is their significance?

Authors:  P Moyle; L Sonoda; P Britton; R Sinnatamby
Journal:  Br J Radiol       Date:  2009-06-22       Impact factor: 3.039

10.  Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients.

Authors:  Till A Heusner; Sherko Kuemmel; Steffen Hahn; Angela Koeninger; Friedrich Otterbach; Monia E Hamami; Klaus R Kimmig; Michael Forsting; Andreas Bockisch; Gerald Antoch; Alexander Stahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-05       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.